Skip to main content

Table 1 Genotypes of the P. vivax populations in admission and relapse episodes

From: Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes

Patient/age (days)a

Date of sample collection (D/M/Y)

Msp1F3

Csp

Microsatellite

MS3.27

MS3.502

MS 6

MS 8

P1/47

AS (12/3/2012)

a

VK247 j

110.7

150.7

252.3

243.7

(106)

RS (25/6/2012)

a

VK247 j

110.7

150.6

252.3

243.7

P2/56

AS (12/3/2012)

a

VK247 j

110.7

150.7

252.2

243.7

(120)

RS (09/7/2012)

a

VK247 j

110.7

150.6

252.3

243.7

P3/50

AS (12/3/2012)

a

VK247 j

110.7

150.7

252.3

243.7

(106)

RS (25/6/2012)

a

VK247 j

110.6

150.6

252.3

243.7

P4/18

AS (23/4/2012)

a

VK247 j

110.7

150.6

252.3

243.7

(44)

RS (05/6/2012)

a

VK247 j

110.8

150.7

252.3

243.8

P5/20

AS (22/5/2012)

a

VK247 k

95.5

150.6

252.3

311.0 + 314.0

(38)

RS (28/6/2012)

b

VK210 a

125.9

190.9

252.2

304.8 + 307.8

P6/22

AS (02/7/2012)

c

VK210 b

103.1

158.8

240.4

311.1 + 314.1

(120)

RS (29/10/2012)

c

VK210 b

103.2

158.8

240.3

311.1 + 314.2

P7/22

AS (16/7/2012)

a

VK210 c

129.8

166.8

252.1

223.8

(92)

RS (15/10/2012)

a

VK210 c

129.7

166.9

252.2

223.9

P8/31

AS (07/2/2013)

a

VK210 d + VK247 l

118.2

158.8

246.1

249.5

(67)

RS (13/4/2013)

a

VK247 l

185.9

150.7

240.3

284.3 + 287.3

P9/22

AS (07/8/2013)

d

VK210 e

146.3

141.7

240.4

272.7 + 275.5

(68)

RS (13/10/2013)

d

VK210 e

146.4

141.7

240.3

272.7 + 275.6

P10/22

AS (18/5/2013)

a + e

VK210 f

133.8

133.1

243.2 + 246.3

287.1 + 289.9

(153)

AS (17/10/2013)

a

VK210 g

133.7

133.1

243.16

218.2

P11/21

AS (11/9/2013)

a

VK210 h + VK247 m

118.2

141.7

246.2

229.5

(40)

RS (20/10/2013)

a

VK210 i + VK247 m

110.6 + 118.2

141.7

240.3

229.5 + 246.7

P12/27

AS (23/10/2013)

f

VK210 b

150.6

190.9

261.2

278.5 + 281.4

(69)

RS (30/12/2013)

f

VK210 b

150.6

191.0

261.2

278.4 + 281.4

  1. Relapse episodes were classified as heterologous when a new allelic variant was observed in this episode for at least one of the markers
  2. AS admission sample, RS relapse sample. Allelic variants that differ between the paired samples from each patient are presented in bold
  3. aThe number of days between the initial admission and the relapse episode is presented in parenthesis below each patient number